Selenium-Binding Protein 1 and Cancer
Selenium-binding protein 1 is an intracellular protein that binds selenium covalently and is thought to mediate the actions of selenium. Cancer is any malignant growth or tumor characterized by abnormal and uncontrolled proliferation of neoplastic cells that disrupt adjacent tissue and have the capacity of spreading to other parts of the body through lymphatic vessels or blood stream.
Selenium and Selenium-Containing Proteins
Selenium is an essential trace mineral with a potent anticancer effect. Epidemiological studies have shown a correlation between high cancer rates and low dietary selenium intake (Klein 2004). The relationship of selenium with cancer was further demonstrated by clinical trials revealing an effect of dietary selenium supplementation on the reduction of total cancer mortality, total cancer incidence, and incidences of prostate, lung, colorectal, and skin cancers. The proposed mechanisms...
- Gladyshev VN (2006) Selenoproteins and selenoproteomes. In: Hatfield DL, Berry MJ, Gladyshev VN (eds) Selenium: its molecular biology and role in human health, 2nd edn. Springer Science + Business Media LLC, Philadelphia, pp 99–114Google Scholar
- Li T, Yang W, Li M, Byun D, Tong C, Nasser S, Zhuang M, Arango D, Mariadason JM, Augenlicht LH (2008) Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res 52:1289–1299CrossRefPubMedGoogle Scholar
- Silvers AL, Lin L, Bass AJ, Chen G, Wang Z, Thomas DG, Lin J, Giordano TJ, Orringer MB, Beer DG, Chang AC (2010) Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 16:2009–2021CrossRefPubMedGoogle Scholar
- Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, Quddus MR, Lawrence WD (2010a) Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum Pathol 41:255–261CrossRefPubMedGoogle Scholar